The addition of human papillomavirus (HPV) DNA testing to either conventional or liquid-based cytology has previously been shown to increase detection rates of high-grade cervical intraepithelial ...

Please provide your email address to receive an email when new articles are posted on . A blood test to detect circulating tumor DNA accurately predicted recurrence of HPV-driven oropharyngeal cancer ...

A novel multifeature human papillomavirus (HPV) whole genome sequencing liquid biopsy assay detected circulating tumor HPV DNA (ctHPV DNA) with 79% sensitivity and 100% specificity up to 7.8 years ...

HealthDay News — Combining human papillomavirus (HPV) DNA testing with cytology testing at first screening resulted in fewer cases of high-grade cervical intraepithelial neoplasia (CIN) lesions and ...

Results of a study to determine the accuracy of a new rapid screening test for HPV (human papillomavirus), created specifically for use in the developing world, have shown it to be 90% accurate in ...

Please provide your email address to receive an email when new articles are posted on . Detection of circulating TTMV HPV DNA appeared significantly associated with clinical N stage HPV-positive ...

Mortality due to cervical cancer comes at an alarming rate. In the Philippines alone, 68% of women diagnosed with cervical ...

Independent physician-owned pathology lab OmniPathology launched an oral lab-developed PCR test that detects HPV. The test, which involves a throat swab, can detect 14 high-risk strains of the virus, ...

A new blood test can identify cancers of the head and neck caused by the human papillomavirus (HPV) up to 10 years before symptoms appear. This is the discovery of Mass General Brigham researchers who ...

A polymerase chain reaction (PCR) test detects genetic material from a pathogen or abnormal cell sample. Ways of collecting samples include a nasal swab, a saliva swab, or taking a sample of blood.